Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pink1 deficiency sustains cell proliferation by reprogramming glucose metabolism through hif1

  • Requejo-Aguilar, Raquel
  • López-Fabuel, Irene
  • Fernández, Emilio
  • Martins, Luis M.
  • Almeida, Angeles
  • Bolaños, Juan P.
PTEN-induced kinase-1 (PINK1) is a Ser/Thr kinase implicated in familial early-onset Parkinson's disease, and was first reported as a growth suppressor. PINK1 loss-of-function compromises both mitochondrial autophagy and oxidative phosphorylation. Here we report that PINK1 deficiency triggers hypoxia-inducible factor-1α (HIF1α) stabilization in cultured Pink1-/- mouse embryonic fibroblasts and primary cortical neurons as well as in vivo. This effect, mediated by mitochondrial reactive oxygen species, led to the upregulation of the HIF1 target, pyruvate dehydrogenase kinase-1, which inhibits PDH activity. Furthermore, we show that HIF1a stimulates glycolysis in the absence of Pink1, and that the promotion of intracellular glucose metabolism by HIF1α stabilization is required for cell proliferation in Pink1 -/- mice. We propose that loss of Pink1 reprograms glucose metabolism through HIF1a, sustaining increased cell proliferation. © 2014 Macmillan Publishers Limited., This work was funded by the Spanish Ministerio de Economia y Competitividad (to J.P.B., grant number SAF2013-41177-R), the Instituto de Salud Carlos III (to J.P.B., grant number RD12/0043/0021; to A.A., grant numbers PI12/00685 and RD12/0014/0007), Junta de Castilla y Leon (to J.P.B., SA003U13), the SP3-People-MC-ITN programme of the European Commission (to J.P.B., 608381 TINTIN), and the European Regional Development Fund. I.L.-F. is the recipient of a FPI Fellowship from the MINECO (Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating pink1

  • Requejo-Aguilar, Raquel
  • López-Fabuel, Irene
  • Jimenez-Blasco, Daniel
  • Fernández, Emilio
  • Almeida, Angeles
  • Bolaños, Juan P.
PMCID: PMC4385472, Using mouse embryonic fibroblasts (MEFs) from DJ1-knockout mice, in the present study, we show that DJ1, by binding with Foxo3a (forkhead box O3a), transcriptionally activates pink1 (phosphatase and tensin homologue deleted on chromosome 10-induced protein kinase-1) gene. Moreover, we demonstrate that, by promoting pink1 expression, DJ1 represses the rate of glycolysis and cell proliferation., This work was funded by the Spanish Ministerio de Economia y Competitividad [SAF2013-41177-R], the Instituto de Salud Carlos III [RD12/0043/0021], the SP3-People-MC-ITN programme of the European Commission [608381], the National Institutes of Drug Abuse/National Institutes of Health (NIH/NIDA) [1R21DA03767801], and the European Regional Development Fund to JPB. AAP was funded by the Instituto de Salud Carlos III [PI12/00685; RD12/0014/0007]. ILB is the recipient of a FPI Fellowship from the Spanish Ministerio de Economia y Competitividad (Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons

  • Veas-Pérez de Tudela, Miguel
  • Maestre, Carolina
  • Delgado-Esteban, María
  • Bolaños, Juan P.
  • Almeida, Angeles
The anaphase-promoting complex/cyclosome (APC/C) is an E3 ubiquitin ligase that regulates cell cycle progression in proliferating cells. To enter the S-phase, APC/C must be inactivated by phosphorylation of its cofactor, Cdh1. In post-mitotic cells such as neurons APC/C-Cdh1 complex is highly active and responsible for the continuous degradation of mitotic cyclins. However, the specific molecular pathway that determines neuronal cell cycle blockade in post-mitotic neurons is unknown. Here, we show that activation of glutamatergic receptors in rat cortical primary neurons endogenously triggers cyclin-dependent kinase-5 (Cdk5)-mediated phosphorylation of Cdh1 leading to its cytoplasmic accumulation and disassembly from the APC3 core protein, causing APC/C inactivation. Conversely, pharmacological or genetic inhibition of Cdk5 promotes Cdh1 ubiquitination and proteasomal degradation. Furthermore, we show that Cdk5-mediated phosphorylation and inactivation of Cdh1 leads to p27 depletion, which switches on the cyclin D1-cyclin-dependent kinase-4 (Cdk4)-retinoblastoma protein (pRb) pathway to allow the S-phase entry of neurons. However, neurons do not proceed through the cell cycle and die by apoptosis. These results indicate that APC/C-Cdh1 actively suppresses an aberrant cell cycle entry and death of neurons, highlighting its critical function in neuroprotection., This work was funded by The Instituto de Salud Carlos III Grants PI12/00685 and RD12/0014/0007 (A.A.P.), RD12/0043/0021 (J.P.B.), FI10/00492 (M.V.-P.d.T.), and CP14/00010 (M.D.-E.), Ministerio de Economia y Competitividad Grant SAF2013-41177-R (J.P.B.), The E.U. SP3-People-MC-ITN programme (608381; J.P.B.), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Astrocyte NMDA receptors' activity sustains neuronal survival through a Cdk5-Nrf2 pathway

  • Jimenez-Blasco, Daniel
  • Santofimia-Castaño, Patricia
  • Gonzalez, Antonio
  • Almeida, Angeles
  • Bolaños, Juan P.
Neurotransmission unavoidably increases mitochondrial reactive oxygen species. However, the intrinsic antioxidant defense of neurons is weak and hence the mechanism whereby these cells are physiologically protected against oxidative damage is unknown. Here we found that the antioxidant defense of neurons is repressed owing to the continuous protein destabilization of the master antioxidant transcriptional activator, nuclear factor-erythroid 2-related factor-2 (Nrf2). By contrast, Nrf2 is highly stable in neighbor astrocytes explaining their robust antioxidant defense and resistance against oxidative stress. We also show that subtle and persistent stimulation of N-methyl-d-aspartate receptors (NMDAR) in astrocytes, through a mechanism not requiring extracellular Ca 2+ influx, upregulates a signal transduction pathway involving phospholipase C-mediated endoplasmic reticulum release of Ca 2+ and protein kinase Cδ activation. Active protein kinase Cδ promotes, by phosphorylation, the stabilization of p35, a cyclin-dependent kinase-5 (Cdk5) cofactor. Active p35/Cdk5 complex in the cytosol phosphorylates Nrf2 at Thr395, Ser433 and Thr439 that is sufficient to promote Nrf2 translocation to the nucleus and induce the expression of antioxidant genes. Furthermore, this Cdk5-Nrf2 transduction pathway boosts glutathione metabolism in astrocytes efficiently protecting closely spaced neurons against oxidative damage. Thus, intercellular communication through NMDAR couples neurotransmission with neuronal survival., DJ-B is the recipient of a FIS Fellowship. PS-C was granted a fellowship from Gobierno de Extremadura (PD10058; Consejería de Empleo, Empresa e Innovación) and European Social Fund. This work was funded by the Spanish Ministerio de Economia y Competitividad (to JPB, grant number SAF2013-41177-R), the Instituto de Salud Carlos III (to JPB, grant number RD12/0043/0021; to AA, grant numbers PI12/00685 and RD12/0014/0007), Junta de Castilla y Leon (to JPB, SA003U13), the SP3-People-MC-ITN program of the European Commission (to JPB, 608381 TINTIN), the National Institutes of Drug Abuse/National Institutes of Health (NIH/NIDA) (to JPB, 1R21DA037678-01) and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Melatonin induces the expression of Nrf2-regulated antioxidant enzymes via PKC and Ca2+ influx activation in mouse pancreatic acinar cells

  • Santofimia-Castaño, Patricia
  • Clea Ruy, Deborah
  • Garcia-Sanchez, Lourdes
  • Jimenez-Blasco, Daniel
  • Fernandez-Bermejo, Miguel
  • Bolaños, Juan P.
  • Salido, Gines M.
  • Gonzalez, Antonio
The goal of this study was to evaluate the potential activation of the nuclear factor erythroid 2-related factor and the antioxidant-responsive element (Nrf2–ARE) signaling pathway in response to melatonin in isolated mouse pancreatic acinar cells. Changes in intracellular free Ca2+ concentration were followed by fluorimetric analysis of fura-2-loaded cells. The activations of PKC and JNK were measured by Western blot analysis. Quantitative reverse transcription–polymerase chain reaction was employed to detect the expression of Nrf2-regulated antioxidant enzymes. Immunocytochemistry was employed to determine nuclear location of phosphorylated Nrf2, and the cellular redox state was monitored following MitoSOX Red-derived fluorescence. Our results show that stimulation of fura-2-loaded cells with melatonin (1 µM to 1 mM), in the presence of Ca2+ in the extracellular medium, induced a slow and progressive increase of [Ca2+]c toward a stable level. Melatonin did not inhibit the typical Ca2+ response induced by CCK-8 (1 nM). When the cells were challenged with indoleamine in the absence of Ca2+ in the extracellular solution (medium containing 0.5 mM EGTA) or in the presence of 1 mM LaCl3, to inhibit Ca2+ entry, we could not detect any change in [Ca2+]c. Nevertheless, CCK-8 (1 nM) was able to induce the typical mobilization of Ca2+. When the cells were incubated with the PKC activator PMA (1 µM) in the presence of Ca2+ in the extracellular medium, we observed a response similar to that noted when the cells were challenged with melatonin 100 µM. However, in the presence of Ro31-8220 (3 µM), a PKC inhibitor, stimulation of cells with melatonin failed to evoke changes in [Ca2+]c. Immunoblots, using an antibody specific for phospho-PKC, revealed that melatonin induces PKCα activation, either in the presence or in the absence of external Ca2+. Melatonin induced the phosphorylation and nuclear translocation of the transcription factor Nrf2, and evoked a concentration-dependent increase in the expression of the antioxidant enzymes NAD(P)H-quinone oxidoreductase 1, catalytic subunit of glutamate-cysteine ligase, and heme oxygenase-1. Incubation of MitoSOX Red-loaded pancreatic acinar cells in the presence of 1 nM CCK-8 induced a statistically significant increase in dye-derived fluorescence, reflecting an increase in oxidation, that was abolished by pretreatment of cells with melatonin (100 µM) or PMA (1 µM). On the contrary, pretreatment with Ro31-8220 (3 µM) blocked the effect of melatonin on CCK-8-induced increase in oxidation. Finally, phosphorylation of JNK in the presence of CCK-8 or melatonin was also observed. We conclude that melatonin, via modulation of PKC and Ca2+ signaling, could potentially stimulate the Nrf2-mediated antioxidant response in mouse pancreatic acinar cells., This work was supported by Junta de Extremadura-FEDER. Patricia Santofimia-Castaño was granted a fellowship from Fundacion Tatiana Perez de Guzman el Bueno. J.P.B. is funded by the Spanish Ministerio de Economia y Competitividad (SAF2013-41177-R), the Instituto de Salud Carlos III (RD12/0043/0021), the SP3-People-MC-ITN programme of the European Commission (608381), the National Institute on Drug Abuse (National Institutes of Health; 1R21DA037678-01), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of Bcl-xL–ATP synthase interaction by mitochondrial cyclin B1–cyclin-dependent kinase-1 determines neuronal survival

  • Veas-Pérez de Tudela, Miguel
  • Delgado-Esteban, María
  • Maestre, Carolina
  • Bobo-Jimenez, Veronica
  • Jimenez-Blasco, Daniel
  • Vecino, Rebeca
  • Bolaños, Juan P.
  • Almeida, Angeles
The survival of postmitotic neurons needs continuous degradation of cyclin B1, a mitotic protein accumulated aberrantly in the damaged brain areas of Alzheimer's disease and stroked patients. Degradation of cyclin B1 takes place in the proteasome after ubiquitylation by the anaphase-promoting complex/cyclosome (APC/C)–cadherin 1 (Cdh1), an E3 ubiquitin ligase that is highly active in neurons. However, during excitotoxic damage—a hallmark of neurological disorders—APC/C–Cdh1 is inactivated, causing cyclin B1 stabilization and neuronal death through an unknown mechanism. Here, we show that an excitotoxic stimulus in rat cortical neurons in primary culture promotes cyclin B1 accumulation in the mitochondria, in which it binds to, and activates, cyclin-dependent kinase-1 (Cdk1). The cyclin B1–Cdk1 complex in the mitochondria phosphorylates the anti-apoptotic protein B-cell lymphoma extra-large (Bcl-xL), leading to its dissociation from the β subunit of F1Fo–ATP synthase. The subsequent inhibition of ATP synthase activity causes complex I oxidative damage, mitochondrial inner membrane depolarization, and apoptotic neuronal death. These results unveil a previously unrecognized role for mitochondrial cyclin B1 in the oxidative damage associated with neurological disorders., This work was funded by Instituto de Salud Carlos III Grants PI12/00685 and RD12/0014/0007 (A.A.P.), RD12/0043/0021 (J.P.B.), FI10/00492 (M.V.-P.d.T.), and CP14/00010 (M.D.-E.), Ministerio de Economia y Competitividad Grant SAF2013-41177-R (J.P.B.), SP3-People-MC-ITN programme of the European Commission Grant 608381 (J.P.B.), and the European Regional Development Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bioenergetics and redox adaptations of astrocytes to neuronal activity

  • Bolaños, Juan P.
Neuronal activity is a high-energy demanding process recruiting all neural cells that adapt their metabolism to sustain the energy and redox balance of neurons. During neurotransmission, synaptic cleft glutamate activates its receptors in neurons and in astrocytes, before being taken up by astrocytes through energy costly transporters. In astrocytes, the energy requirement for glutamate influx is likely to be met by glycolysis. To enable this, astrocytes are constitutively glycolytic, robustly expressing 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), an enzyme that is negligibly present in neurons by continuous degradation because of the ubiquitin-proteasome pathway via anaphase-promoting complex/cyclosome (APC)-Cdh1. Additional factors contributing to the glycolytic frame of astrocytes may include 5′-AMP-activated protein kinase (AMPK), hypoxia-inducible factor-1 (HIF-1), pyruvate kinase muscle isoform-2 (PKM2), pyruvate dehydrogenase kinase-4 (PDK4), lactate dehydrogenase-B, or monocarboxylate transporter-4 (MCT4). Neurotransmission-associated messengers, such as nitric oxide or ammonium, stimulate lactate release from astrocytes. Astrocyte-derived glycolytic lactate thus sustains the energy needs of neurons, which in contrast to astrocytes mainly rely on oxidative phosphorylation. Neuronal activity unavoidably triggers reactive oxygen species, but the antioxidant defense of neurons is weak; hence, they use glucose for oxidation through the pentose-phosphate pathway to preserve the redox status. Furthermore, neural activity is coupled with erythroid-derived erythroid-derived 2-like 2 (Nrf2) mediated transcriptional activation of antioxidant genes in astrocytes, which boost the de novo glutathione biosynthesis in neighbor neurons. Thus, the bioenergetics and redox programs of astrocytes are adapted to sustain neuronal activity and survival. Developing therapeutic strategies to interfere with these pathways may be useful to combat neurological diseases., J.P.B. is funded by the MINECO (SAF2013‐41177‐R; RTC‐2015‐3237‐1), the Instituto de Salud Carlos III (RD12/0043/0021), the E.U. SP3‐People‐MC‐ITN programme (608381), the E.U. BATCure grant (666918), the European Regional Development Fund, and the NIH/NIDA (1R21DA037678‐01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes

  • López-Fabuel, Irene
  • Le Douce, Juliette
  • Logan, Angela
  • James, Andrew M.
  • Bonvento, Gilles
  • Murphy, Michael P.
  • Almeida, Angeles
  • Bolaños, Juan P.
Neurons depend on oxidative phosphorylation for survival, whereas astrocytes do not. Mitochondrial respiratory chain (MRC) complexes can be organized in higher structures called supercomplexes, which dictate MRC electron flux and energy efficiency. Whether the specific metabolic shapes of neurons and astrocytes are determined by the specific organization of MRC complexes is unknown. Here, we found that, in astrocytes, most complex I is free, resulting in poor mitochondrial respiration but high reactive oxygen species (ROS) production. In contrast, neurons show complex I to be mostly embedded into supercomplexes, thus resulting in high mitochondrial respiration and low ROS production. Thus, MRC organization dictates different bioenergetics preferences of neurons and astrocytes impacting on ROS production, possibly playing a role in neurodegenerative diseases., J.P.B. is funded by the Ministry of Economy and Competitiveness (SAF2013-41177-R), Instituto de Salud Carlos III (RD12/0043/0021), European Union (EU) SP3-People-MC-ITN Programme (608381), EU BATCure Grant 666918, and NIH/National Institute on Drug Abuse Grant 1R21DA037678-01. A.A. is funded by Instituto de Salud Carlos III (PI12/00685 and RD12/0014/0007)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

α-Ketoglutarate dehydrogenase complex moonlighting: ROS signalling added to the list

  • Fernández, Emilio
  • Bolaños, Juan P.
An Editorial highlight for ‘Reductions in the mitochondrial enzyme α-ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental?’, J.P.B. is funded by the MINECO (SAF2013-41177-R), the Instituto de Salud Carlos III (RD12/0043/0021), the E.U. SP3-People-MC-ITN programme (608381), the EU BATCure grant (666918), andthe NIH/NIDA (1R21DA037678-01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial control of cell bioenergetics in Parkinson's disease

  • Requejo-Aguilar, Raquel
  • Bolaños, Juan P.
PMCID: PMC5065935, Parkinson disease (PD) is a neurodegenerative disorder characterized by a selective loss of dopaminergic neurons in the substantia nigra. The earliest biochemical signs of the disease involve failure in mitochondrial-endoplasmic reticulum cross talk and lysosomal function, mitochondrial electron chain impairment, mitochondrial dynamics alterations, and calcium and iron homeostasis abnormalities. These changes are associated with increased mitochondrial reactive oxygen species (mROS) and energy deficiency. Recently, it has been reported that, as an attempt to compensate for the mitochondrial dysfunction, neurons invoke glycolysis as a low-efficient mode of energy production in models of PD. Here, we review how mitochondria orchestrate the maintenance of cellular energetic status in PD, with special focus on the switch from oxidative phosphorylation to glycolysis, as well as the implication of endoplasmic reticulum and lysosomes in the control of bioenergetics., J.P.B. is funded by the MINECO (SAF2013-41177-R; RTC-2015-3237-1), the ISCIII (RD12/0043/0021), the EU SP3-People-MC-ITN program (608381), the EU BATCure grant (666918), the NIH/NIDA (1R21DA037678-01)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NRF2 orchestrates the metabolic shift during induced pluripotent stem cell reprogramming

  • Hawkins, Kate E.
  • Fernández, Emilio
  • Bolaños, Juan P.
  • Duchen, Michael R.
  • McKay, Tristan R.
This is an open access article under the CC BY license.-- et al., The potential of induced pluripotent stem cells (iPSCs) in disease modeling and regenerative medicine is vast, but current methodologies remain inefficient. Understanding the cellular mechanisms underlying iPSC reprogramming, such as the metabolic shift from oxidative to glycolytic energy production, is key to improving its efficiency. We have developed a lentiviral reporter system to assay longitudinal changes in cell signaling and transcription factor activity in living cells throughout iPSC reprogramming of human dermal fibroblasts. We reveal early NF-κB, AP-1, and NRF2 transcription factor activation prior to a temporal peak in hypoxia inducible factor α (HIFα) activity. Mechanistically, we show that an early burst in oxidative phosphorylation and elevated reactive oxygen species generation mediates increased NRF2 activity, which in turn initiates the HIFα-mediated glycolytic shift and may modulate glucose redistribution to the pentose phosphate pathway. Critically, inhibition of NRF2 by KEAP1 overexpression compromises metabolic reprogramming and results in reduced efficiency of iPSC colony formation., K.E.H. and S.J. were partly funded by St George’s University of London Enterprize Fund. J.M.K.M.D. and S.N.W. are funded by ERC grant Somabio (260862). T.R.M. and S.N.W. are funded by the NC3Rs (NC/L001780/1). J.P.B. is funded by MINECO (SAF2013-41177-R), ISCIII (RD12/0043/0021), EU-SP3-People-MC-ITN (608381), and NIH/NIDA (1R21DA037678-01). V.N.K. is funded by Action Medical Research and The Henry Smith Charity (GN2158), and P.J.K. is funded by Barts and the London Charity (417/2088). T.R.M. and J.B. were each funded by EU Horizon2020; BATCure 666918., Open access funded by European Research Council., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Current technical approaches to brain energy metabolism

  • Barros, L. Felipe
  • Bolaños, Juan P.
  • Bonvento, Gilles
  • Bouzier-Sore, Anne-Karine
  • Brown, Angus
  • Hirrlinger, Johannes
  • Kasparov, Sergey
  • Kirchhoff, Frank
  • Murphy, Anne N.
  • Pellerin, Luc
  • Robinson, Michael B.
  • Weber, Bruno
Neuroscience is a technology‐driven discipline and brain energy metabolism is no exception. Once satisfied with mapping metabolic pathways at organ level, we are now looking to learn what it is exactly that metabolic enzymes and transporters do and when, where do they reside, how are they regulated, and how do they relate to the specific functions of neurons, glial cells, and their subcellular domains and organelles, in different areas of the brain. Moreover, we aim to quantify the fluxes of metabolites within and between cells. Energy metabolism is not just a necessity for proper cell function and viability but plays specific roles in higher brain functions such as memory processing and behavior, whose mechanisms need to be understood at all hierarchical levels, from isolated proteins to whole subjects, in both health and disease. To this aim, the field takes advantage of diverse disciplines including anatomy, histology, physiology, biochemistry, bioenergetics, cellular biology, molecular biology, developmental biology, neurology, and mathematical modeling. This article presents a well‐referenced synopsis of the technical side of brain energy metabolism research. Detail and jargon are avoided whenever possible and emphasis is given to comparative strengths, limitations, and weaknesses, information that is often not available in regular articles., Fondecyt, Grant Number: 1160317; MINECO, Grant Numbers: SAF2016‐78114‐R and RTC‐2015‐3237‐1; CIBERFES, Grant Numer: CB16/10/00282; SP3‐People‐MC‐ITN program, Grant Number: 608381; EU BATCure, Grant Number: 666918; FEDER (European regional development fund); Investissement d'Avenir, Grant Number: ANR‐11‐INBS‐0011; French State in the context of the “Investments for the future” Program IdEx and the LabEx TRAIL, Grant Numbers: ANR‐10‐IDEX and ANR‐10‐LABX‐57; French–Swiss ANR‐FNS, Grant Numer: ANR‐15‐ CE37‐0012. University of Nottingham; BBSRC, Grant Numers: BB/L019396/1 and BB/K009192/1; MRC, Grant Number: MR/L020661/1; Deutsche Forschungsgemeinschaft, Grant Numers: DFG SPP 1757, SFB 894, and FOR 2289; European Commission, Grant Number: H2020‐FETPROACT 732344; Neurofibres, Grant Number: H2020‐MSCA‐ITN‐722053 EU‐GliaPhD; US National Institutes of Health, Grant Number: R01NS087611; Teva Pharmaceuticals; Agilent Technologies. IdEx, Grant Number: ANR‐10‐IDEX‐03‐02; French–Swiss ANR‐FNS, Grant number: 310030E‐164271; National Institutes of Neurologic Disease and Stroke at the National Institutes of Health, Grant Numer: R01 NS077773; University of Zurich and the Swiss National Science Foundation; Comisión Nacional de Investigación Científica y Tecnológica, Grant Numer: PB 01; Fondo Nacional de Desarrollo Científico y Tecnológico, Grant Numer: 1160317; Ministerio de Economía y Competitividad, Grant Numer: RTC‐2015‐3237‐1,SAF2016‐78114‐R; Agence Nationale de la Recherche, Grant Numers: ANR‐10‐IDEX, ANR‐10‐IDEX‐03‐02, ANR‐10‐LABX‐57, ANR‐11‐INBS‐0011, and ANR‐15‐ CE37‐0012; Biotechnology and Biological Sciences Research Council, Grant Numers: BB/L019396/1 and BB/K009192/1; Medical Research Council, Grant Numer: MR/L020661/1., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial Complex I Activity is Conditioned by Supercomplex I–III2–IV Assembly in Brain Cells: Relevance for Parkinson’s Disease

  • López-Fabuel, Irene
  • Resch-Beusher, Monica
  • Carabias-Carrasco, Mónica
  • Almeida, Angeles
  • Bolaños, Juan P.
The assembly of complex I (CI) with complexes III (CIII) and IV (CIV) of the mitochondrial respiratory chain (MRC) to configure I–III- or I–III–IV-containing supercomplexes (SCs) regulates mitochondrial energy efficiency and reactive oxygen species (mROS) production. However, whether the occurrence of SCs impacts on CI specific activity remains unknown to our knowledge. To investigate this issue, here we determined CI activity in primary neurons and astrocytes, cultured under identical antioxidants-free medium, from two mouse strains (C57Bl/6 and CBA) and Wistar rat, i.e. three rodent species with or without the ability to assemble CIV into SCs. We found that CI activity was 6- or 1.8-fold higher in astrocytes than in neurons, respectively, from rat or CBA mouse, which can form I–III2–IV SC; however, CI activity was similar in the cells from C57Bl/6 mouse, which does not form I–III2–IV SC. Interestingly, CII–III activity, which was comparable in neurons and astrocytes from mice, was about 50% lower in astrocytes when compared with neurons from rat, a difference that was abolished by antioxidants- or serum-containing media. CIV and citrate synthase activities were similar under all conditions studied. Interestingly, in rat astrocytes, CI abundance in I–III2–IV SC was negligible when compared with its abundance in I–III-containing SCs. Thus, CIV-containing SCs formation may determine CI specific activity in astrocytes, which is important to understand the mechanism for CI deficiency observed in Parkinson’s disease., J.P.B. is funded by MINECO (SAF2013-41177-R, SAF2016-78114-R), CIBER on Frailty and Aging from the Instituto de Salud Carlos III (CB16/10/00282), E.U. SP3-People-MC-ITN programme (608381), EU BATCure Grant (666918) and FEDER (European regional development fund). A.A.P. is funded by the Instituto de Salud Carlos III (RD12/0014/0007)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants

  • López-Fabuel, Irene
  • Martín-Martín, Lucía
  • Resch-Beusher, Monica
  • Azkona, Garikoitz
  • Sánchez-Pernaute, Rosario
  • Bolaños, Juan P.
Brain mitochondrial complex I (CI) damage is associated with the loss of the dopaminergic neurons of the Substantia Nigra in Parkinson's Disease (PD) patients. However, whether CI inhibition is associated with any alteration of the mitochondrial respiratory chain (MRC) organization in PD patients is unknown. To address this issue, here we analyzed the MRC by blue native gel electrophoresis (BNGE) followed by western blotting, in mitochondria purified from fibroblasts of patients harboring PD-relevant Pink1 mutations. We found a decrease in free CI, and in free versus supercomplexes (SCs)-assembled CI in PD; however, free complex III (CIII) was only modestly affected, whereas its free versus SCs-assembled forms decreased. Interestingly, complex IV (CIV) was considerably lost in the PD samples. These results were largely confirmed in mitochondria isolated from cultured neurons from Pink1-/- mice, and in cultured neurons and forebrain samples from the PD-related Dj1-/- mice. Thus, besides CI damage, the MRC undergoes a profound structural remodeling in PD likely responsible for the energetic inefficiency and mitochondrial reactive oxygen species (mROS) over-production observed in this disease., J.P.B. is funded by MINECO (SAF2016-78114-R; RTC-2015-3237-1), CIBERFES (CB16/10/00282), E.U. SP3-People-MC-ITN programme (608381), EU BATCure grant (666918) and FEDER (European regional development fund). R.S.P. is funded by the Joint Program in Neurodegenerative Diseases (DAMNDPATHS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program

  • Fitzpatrick, Lorna M.
  • Hawkins, Kate E.
  • Delhove, Juliette M. K. M.
  • Fernández, Emilio
  • Soldati, Chiara
  • Bullen, Louise F.
  • Nohturfft, Axel
  • Waddington, Simon N.
  • Medina, Diego L.
  • Bolaños, Juan P.
  • McKay, Tristan R.
Human neural development begins at embryonic day 19 and marks the beginning of organogenesis. Neural stem cells in the neural tube undergo profound functional, morphological, and metabolic changes during neural specification, coordinated by a combination of exogenous and endogenous cues. The temporal cell signaling activities that mediate this process, during development and in the postnatal brain, are incompletely understood. We have applied gene expression studies and transcription factor-activated reporter lentiviruses during in vitro neural specification of human pluripotent stem cells. We show that nuclear factor κB orchestrates a multi-faceted metabolic program necessary for the maturation of neural progenitor cells during neurogenesis., L.M.F. and K.E.H. were partly funded by St. George's, University of London. T.R.M., J.M.K.M.D., and S.N.W. were funded by ERC grant “Somabio” (260862) and the NC3Rs (NC/L001780/1). J.P.B. is funded by MINECO (SAF2016-78114-R) CIBERFES (CB16/10/00282), SP3-People-MC-ITN program (608381). L.M.F., T.R.M., C.S., D.L.M., and J.P.B. are all funded by Horizon 2020 grant BATCure (666918). S.N.W. received funding from UK Medical Research Council grants (G1000709 and MR/N026101/1, MR/R015325/1, MR/P026494/1, and MR/N019075/1) and from SPARKS (17UCL01)., Peer reviewed